How BMS Is Tackling Clinical Trial Diversity

Site Selection Is A Critical Component

 
• By Alaric DeArment
COVID-19 studies helped bring trial diversity to the forefront • Source: Shutterstock

More from Diversity & Inclusion

More from ESG